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Abstract  
  
Tapak dara or Madagascar Periwinkle (Catharanthus roseus [L] G.Don), a natural plant, is 
empirically reported to have promising anticancer activity. To elucidate its mechanism, a 
research was conducted to investigate the possible ethanol extract of  C. roseus in inducing 
apoptosis on breast cancer cell line (T47D). Antioxidant activity of C. roseus was investigated as 
well. Sub-G1 flowcytometric apoptotic analysis result showed that extract of C. roseus at 6.25 
μg/mL induced apoptosis for 26.365%. Increasing extract concentration resulted an increasing 
apoptotic level as well, extract at concentration of 12.5 μg/mL induced apoptosis for 22.235%.  
Meanwhile doxorubicin at concentration of 10 μg/mL induced apoptosis for 36.055%. The 
antioxidant activity was determined by using in vitro assay: inhibition of  2,2-diphenyl-1-
picrylhydrazyl (DPPH) scavenging activity. Antioxidant activity of C. roseus extract were 
compared to quercetin and butylated hydroxyanisol (BHA), as positive controls.  The results 
showed that DPPH IC50 of C. roseus extract, quercetin and BHA were 358.411 μg/mL, 19.200 
μg/mL  and  94.178 μg/mL, respectively. We suggest that C. roseus extract had a potential 
anticancer activity by inducing apoptosis. 
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INTRODUCTION 
 
Breast cancer is the most common cancer 
among women and the second leading cause of 
cancer deaths in women after lung cancer (Lopez 
and Sekharam., 2008). It is estimated that one of 
eight women will be diagnosed with breast cancer in 
women (Chen and Yan, 2007). Worldwide, one 
million women are estimated to be newly diagnosed 
with breast cancer each year (Hanf and Gonder, 
2005; Abdolmohammadi et al., 2009). Cancer 
chemoprevention applies specific natural or 
synthetic chemical compounds to inhibit or reverse 
carcinogenesis and to suppress the development of 
cancer from premalignant lesions (Sarkar and Li, 
2007; Abdolmohammadi et al., 2009). A major 
problem with present cancer chemotherapy is the 
serious deficiency of active drugs for the curative 
therapy of tumors (Valeriote et al., 2002; Kinghorn 
et al., 2003; Abdolmohammadi et al., 2009). The 
chemotherapeutic drugs including etoposide, 
camptothecin, vincristine, cis-platinum, 
cyclophosphamide, paclitaxel (Taxol), 5- 
fluorouracil and doxorubicin have been observed to 
induce apoptosis in cancer cells (Kaufman et al., 
2000; Johnstone et al., 2002; Abdolmohammadi et 
al., 2008). Among them, the agents that alter the cell 
cycle have been of particular interest, since cell 
cycle regulation is the basic mechanism underlying 
cell fate, i.e., proliferation, differentiation or acquire 
death (Dobashi et al., 2003;  Abdolmohammadi et 
al., 2008).  
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Apoptosis, a type of programmed cell death, 
is an active process. It is a normal component of the 
development and health of multicellular organisms. 
The study of apoptosis is an important field of 
biological inquiry since a deficiency or an excess of 
apoptosis is one of the causes for cancers, 
autoimmune disorders, and many other diseases. 
Accordingly, a quick and easy assay for 
quantification of apoptosis would be very useful for 
many biological researchers (Ribble et al., 2005). 
Apoptosis was distinguished from necrosis, which 
was associated with acute injury to cells. Apoptosis 
is characterized by nuclear chromatin condensation, 
cytoplasmic shrinking, dilated endoplasmic 
reticulum, and membrane blebbing. Mitochondria 
remain unchanged morphologically (Somani et al., 
2010). Apoptosis is an essential process in both 
multi-cellular development, and in maintaining 
cellular homeostasis. Moreover, failure of damaged 
cells to undergo apoptosis contributes to the 
progression of cancer as it allows the persistence of 
DNA damaged cells. Therefore, it is interesting to 
understand apoptotic signalling pathways in different 
cancer types. Apoptosis is morphologically defined 
by cell shrinkage, membrane blebbing, chromatin 
condensation and formation of apoptotic bodies 
(Mooney et al., 2002). Inducing an apoptotic 
response is the goal of most current 
chemotherapeutic interventions against cancer. The 
main action of anticancer agents is by triggering the 
apoptotic pathway. However, intrinsic alterations in 
the apoptotic pathway are a hallmark of cancer cells 
and are considered to be a major cause of drug 
efficacy (Lowe and Lin, 2002; Waxman and 
Schwartz, 2003; Shkreta et al., 2008). Clinically, 
apoptosis has been found to be an important 
mechanism in the action of radiation and many 
chemotherapeutic drugs (Kaufmann, 1989; Telford 
et al., 1994). Defects in apoptotic signalling are 
believed to be an important factor in successfull 
cancer development (Schwartzman and Cidlowski, 
1992; Telford et al., 1994).  
Lipid peroxidation is a free radical mediated 
phenomenon in biological tissues where poly 
unsaturated fatty acids are generally abundant. The 
Lipid peroxidation content is one of the most 
frequently used parameters for assessing the 
involvement of free radicals in cell damage. The 
probable reason for the elevated level of serum lipid 
peroxide in breast carcinoma may be due to 
defective antioxidant system which leads to the 
accumulation of lipid peroxides in cancer tissue 
which are released into the blood stream. In breast 
cancer tissue, the MDA level in stage IV was 
significantly higher as compared to stage I indicating 
increased free radical activity with increasing 
severity of cancer (Sinha et al., 2009). Lipid 
peroxidations are evidenced by the formation of 
thiobarbituric acid reactive substances (TBARS), 
lipid hydroperoxides (LOOH) and conjugated dienes 
(CD) as well as the status of the antioxidants 
superoxide dismutase (SOD), catalase (CAT), 
reduced glutathione (GSH), glutathione peroxidase 
(GPx) and glutathione-S-transferase (GST) in breast 
cancer tissues were enhanced compared to control 
(Kumaraguruparan et al., 2002). Antioxidant CAT, 
SOD also act as anti-carcinogens and inhibitors at 
initiation and promotion/transformation stage in 
carcinogenesis. Mutation caused by potassium 
superoxide in mammalian cells is blocked by SOD.
 
 
Plasma DNA strand scission caused by 
xanthine/xanthine oxidase is prevented by SOD and 
catalase enzymes (Sinha et al., 2009). 
One of the approaches used in drug discovery 
is the ethnomedical data approach, in which the 
selection of a plant is based on the prior information. 
C. rosues was used as a remedy in cancer related 
diseases. . Craceus (L.) G. Don (Apocynaceae), a 
perennial plant, commonly exists in tropical 
countries. It is more known as Madagascar 
periwinkle, the local name in Indonesia is Tapak 
dara. Aerial part of the plant contains about 90 
different alkaloids. The isolation and purification of 
these indole alkaloids have been extensively studied 
(Sapi and Massiot., 1994), the most abundant ones 
are the monomers like catharanthine and vincloline. 
Two of the common anti-cancer drugs which are 
derived from this plant are vincristine and 
vinblastine. Crude extracts of C. roseus using 50 and 
100% methanol had significant anticancer activity 
against different cell types in vitro at <15 μg/mL) 
(Ueda et al., 2002). Crude decoction (200 mg and 1 
g herb/mL water) showed moderate in vitro anti-
angiogenesis effects (Ghosh and Gupta, 1980; 
Chattopadhyay et al, 1991, 1992). In this study, we 
have examined the antioxidant  and  apoptosis 
properties of the  C. roseus extract.  
 
METHODS    
Plant material  
C. roseus  was collected from Bogor-west 
Java plantation (May 2009). The aerial part and root 
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were collected, kept under dry tunnel (40-45
0
C) and 
chopped finely using a blender.  
 
Preparation of extract 
One kilogram of dried and chopped mateial 
were extracted with distilled ethanol by maserasi 
extraction,  filtered and evaporated using rotatory 
evaporator, produced ethanol extract of C. roseus 
162.5 g (16.25%). The ethanol extract was stored at 
4 
o
C.  The extract was dissolved in DMSO and 
subsequently diluted to appropriate working 
concentrations with DMEM culture medium (Tan et 
al., 2005). 
 
Cell culture 
The human breast cancer T47D cell line was 
obtained from the The Indonesian Institute of 
Sciences of Sciences Research Centre for Chemistry, 
Natural Products, Food and Pharmaceuticals 
Division, Bandung (Indonesia). The cells were 
grown and maintained in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 10% 
(v/v) foetal bovine serum (FBS) supplemented with 
100 U/mL of penicillin, 100 g/mL of streptomycin at 
37
0
C in a humidified atmosphere of 5% CO2  
(Mooney et al., 2002; Tan et al., 2005).  
 
Apoptosis assay 
Cells were used in apoptotic studies when 
80% confluence was reached in T25 flasks. Cells 
were harvested with trypsin-EDTA (0.25%-0.038%), 
washed with PBS. T47D cells were  seeded into 12 
well plate at the density 10
4 
cells/well incubated for 
24 h  with various concentrations of extracts. After 
24 h incubated, untreated and treated cell were 
rinsed with phosphate buffered saline (PBS), fixed 
with trypsin-EDTA and incubated 37
0
C for 5 
minutes. Afterwards, the medium was added in ratio 
3:1 (medium: trypsin-EDTA) and centrifuged at 
1500 rpm for 5 minutes. Supernatant was discarded. 
The pellet was added with 70% ethanol, and then 
incubated in 4
0
 C for 5 minutes. The incubated cells 
were further centrifuged at 1500 rpm for 5 minutes, 
and the supernatant was discarded. The cells were 
stained with Propidium iodide (PI) solution (in PBS) 
in the final concentration of 2 µg/ml. The cell 
suspensions were placed in the dark by wrapping up 
the tubes with aluminium foil for  15 minutes prior 
to flow cytometric analysis. The apoptosis assay was 
analyzed by cell cycle analysis using flow cytometer. 
The apoptotic cells were determined by sub G1 area 
from cell cycle analysis and it was presented as 
percentage of cells.  
 
Antioxidant assay 
The DPPH assay was carried out as described 
by Unlu et al (2003), Han et al. (2004) and Frum and 
Viljoen (2006). Pipette 50  µL of sample (C. roseus 
extract, quercetin and BHA) of various 
concentrations of the samples (125; 62.5; 31.25; 
15.625; 7.813 and 3.906 μg/mL) entered at the 
microplate and then were added 200  µL of 0.077 
mmol/L methanol solution of DPPH and the reaction 
mixture was shaken vigorously and kept in the dark 
for 30 min at room temperature. Furthermore, DPPH 
scavenging activity was determined by microplate 
reader at 517 nm. The radical scavenging activity of 
each sample was expressed by the ratio the of 
lowering of the absorption of DPPH (%), relative to 
the absorption (100%) of DPPH solution in the 
absence of test sample (negative control).  
 Ac
scavenging %  =
Ac  -  As
x 100
          
where  As and Ac  are absorbance at 517 nm of the 
reaction mixture with samples and without sample, 
respectively 
RESULTS 
Morphology  
Treatment of cells with C. roseus extract at 
concentrations of 6.25; 12.5; 25; 50 and 100 μg/mL 
respectively, caused morphological changes 
compared to normal cells and this showed indication 
of apoptosis (Figures 1B, 1C, 1D, 1E, 1F). 
Morphological changes observed in the treated cells 
included cell shrinkage, lead to membrane rupture. 
Higher concentrations of C. roseus extract cause 
more morphological changes, indicating that 
apoptosis occurred in cells.  
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Figure 1:  Morphological changes T47D cells treated with C. roseus extract. (A = untreated T47D cells (1×104)); 
B = cells treated with C. roseus extract at a concentration of 6.25 µg/ml; C = cells treated 12.5 µg/mL; 
D = cells treated 25 µg/mL; E = cells treated 50 µg/mL;  F = cells treated 100 µg/mL) 
 
Sub G1 apoptosis 
The effect of C. roseus  extract on cell cycle 
was analyzed by flow cytometry in duplo using 
concentration of C. roseus  extract  6.25; 12.5; 25; 
50 and 100 μg/mL, respectively. Figure 2 showed  
that sub G1 apoptotic content was markedly 
increased when cells were treated with C. roseus  
extract. The sub G1 average of untretaed was formed 
at 0.465 % (Figure 2), whereas a concentration of 
6.25  µg/mL resulted in 6.925 % of cells being in sub 
G1 phase. This proportion of cells further increased 
at the extract concentration of 25 µg/mL (26.35%),  
concentration 50 µg/mL (37.475%) and finally the 
increased concentration decreased the sub G1 
apoptotic content (10.78%).  
Antioxidant activity 
The DPPH free radical scavenging activity of  
C. roseus extract at various concentrations was 
measured to know the antioxidant activity. 
Quercetine and BHA have been used as positive 
controls. The IC50 (median inhibition concentration) 
is defined as a concentration of samples to scavenge 
DPPH free radical 50 %. The DPPH free radical 
scavenging activity of  C. roseus extract,  quercetin 
and BHA can be found in Table 1. The C. roseus 
extract had a lowest antioxidant activity compared to 
quercetin and BHA.  
 
 
 
 
Figure 2A. Effect C. roseus extract on T47D cell cycle progression. 
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Figure 2B. Effect C. roseus extract on T47D cell cycle progression (A=Untreated 1x104cells; B= C.roseus 6.25 
μg/mL  ; C= C.roseus 12.5 μg/mL; D= C.roseus 25 μg/mL; E= C.roseus 50μg/mL; F= C.roseus 100 μg/mL; 
G=doxorubicin 10 μg/mL 
 
 
Table 1. Antioxidant activity of C. roseus extract 
 
No Antioxidant agents IC50  (μg/mL) 
1 C. roseus extract 358.411 
2 Quercetin 19.200 
3 BHA 94.178 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION  
 
Apoptosis is characterized by fragmentation 
of nuclear chromatin into fragments approximately 
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20 base pairs in length. Apoptosis is known to play a 
role in maintaining homeostasis and known to occur 
in mammals (McCloskey et al., 1994). The flow 
cytometric method has several advantages over the 
electrophoretic method. It analyzes a cell population 
one cell at a time and thereby allows  discrimination 
of subsets within the main population. By selecting 
out the apoptotic subset, we can therefore quantitate 
the percentage of apoptotic cells in each sample.   
C. roseus induced apoptosis in T47D cell line. 
The percentage of apoptotic cells were 6,93%, 
26,35% and 37,48% with concentrations of extract 
6.25µg/mL, 25 µg/mL  and 50 µg/mL, respectively. 
The more information can be found in Fig 1, 2A and 
2B.  This result were consistent with previous 
studies that the C. roseus extract is able to induce 
DNA fragmentation. In each case, DNA 
fragmentation was characterised by 
oligonucleosomal size fragments of about 180-200 
base pairs (bp), a well-known feature indication of 
programmed cell death (Compton 1992;  Ahmad et 
al., 2010). The apototic effect of C. roseus extract 
were due to the presence of compounds, such as 
vinblastine which have anti-leukaemic properties in 
vitro (Caron and Herwood 2007). Vinblastine is one 
of the first vinca alkaloids that identified to have 
anti-tumour activity (Nobili et al., 2009). Further 
analysis of the C. roseus extract should be performed 
according to the American National Cancer Institute 
criterion that the IC50 limit to consider a crude 
extract promising for further purification be lower 
than 30 µg/ml (Suffness and Pezzuto 1990; Ahmad 
et al., 2010). C. roseus crude aqueous extract at very 
low doses inhibited the proliferation of Jurkat cells. 
The DNA fragmentation result showed that the 
cytotoxicity effect of the extract was due to 
programmed cell death. The extract contained 
compounds that specifically induce cell death in 
Jurkat cells (Okonogi et al. 2007; Nobili et al. 2009; 
Ahmad et al., 2010). Two vinca alkaloids from C. 
roseus, vinblastine, and vincristine are widely used 
in cancer therapy (Comin-Anduix, 2001). Both drugs 
inhibit the self-assembly of tubulin into microtubules 
at substoichiometric concentrations by forming a 
tubulin-drug complex at the end of a growing 
microtubule and thus blocking self-assembly 
(Margolis et al., 1980; Comin-Anduix, 2001). In 
addition, it is known that vinblastine induces G2/M 
arrest and subsequent apoptosis in different cell lines 
(Fan et al., 2001; Comin-Anduix, 2001). 
Sample which contain antioxidant compounds 
will react with DPPH free radical to produce color 
change from purple to yellow (Kikugawa et al., 
1999; Gordon, 2001). The changes in colour that was 
proportional to the concentration of sample were 
further measured at 517nm (Miliauskas et al., 2003). 
The antioxidant assay showed that sample had 
lowest antioxidant activity compared to BHA and 
quercetine with the IC50 values are 358; 94 and 19 
μg/mL, respectively. However, C. roseus extract 
induced apoptosis. This result was consistent with 
previous research. ROS intermediates for apoptosis 
signaling was demonstrated by the following four 
observations: (1) Antioxidants could inhibit a certain 
apoptosis; (2) generation of hydrogen peroxide 
(ROS) was detected in the cells undergoing 
apoptosis; (3) extracellular addition of ROS can 
induce apoptosis and (4) downregulation of 
intracellular anti-oxidant level can induce apoptosis. 
The involvement of ROS in apoptosis is also 
supported by the observation that manganese 
superoxide dismutase (MnSOD), which inactivates 
mitochondrial superoxide anion that has leaked from 
the electron transport (Higuchi et al., 1998). ROS 
Hydrogen peroxide (H2O2) is able to induce 
apoptosis (Ray et al., 2000).  
Hence, in our current results, we conclude that 
C. roseues extract had potential anticancer property 
through ROS and apoptosis induction. Investigation 
to know the apoptotic mechanism induced by C. 
roseus extract should be pursued. 
 
CONCLUSIONS 
 
C. roseus [L] G.Don extract induced 
apoptosis in T47D cell line, but had no antioxidant 
property. 
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